In 2022, India found itself second only to China in the global tally of hepatitis B and C cases, with a staggering 3.5 crore infections, as per the latest report from the World Health Organization (WHO).
This report, released on Tuesday, revealed that globally, 254 million individuals battled hepatitis B, while 50 million grappled with hepatitis C during the same year.
In 2022, India found itself second only to China in the global tally of hepatitis B and C cases, with a staggering 3.5 crore infections, as per the latest report from the World Health Organization (WHO). This report, released on Tuesday, revealed that globally, 254 million individuals battled hepatitis B, while 50 million grappled with hepatitis C during the same year.
